search
Back to results

Improving Walking With Heel-To-Toe Device

Primary Purpose

Parkinson

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Heel2Toe
No-feedback control group
Sponsored by
McGill University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Parkinson focused on measuring gait, walking capacity, neuroplasticity, motor learning, quality of life

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of Parkinson Disease and be independent in ambulation without use of walking aid

Exclusion Criteria:

  • exercising three or more time per week;
  • Had any additional illness that restricted their function
  • Showing difficulty reading, understanding or speaking either French or English

Sites / Locations

  • McGill University Health Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Other

Arm Label

Heel2Toe Group

No-feedback Control Group (Control group)

Arm Description

The Heel2Toe group will have 5 therapy sessions to learn to trigger the sensor with a strong heel strike and how to use device for home practice for 3 months. During the home practice, participants will be instructed to walk with the device for a minimum of 10 minutes per day in feedback mode. They will be provided with a workbook outlining simple exercises targeting functions needed to walk well (Walk-BEST Workbook) in paper and as a mobile app.

The Control group will do the same 5 sessions of training and 3 months of practice but without the Heel2Toe device in feedback mode, just in data acquisition mode. They will be provided with a workbook outlining simple exercises targeting functions needed to walk well (Walk-BEST Workbook) in paper and as a mobile app.

Outcomes

Primary Outcome Measures

Reliable Change in Six-Minute Walk Test
Performance-rated outcome
Change in Standardized Walking Obstacle Course (SWOC)
Performance-rated outcome of challenges experienced with starting, stopping, turning, making motor decisions. The metric is the time to complete a 12.2-m long, 0.92-m wide curved pathway, with obstacles commonly encountered in daily life.

Secondary Outcome Measures

Safety (Falls)
Self-reported number of falls during study period
Technology acceptability (System Usability Scale)
Patient-reported outcome on satisfaction and intent-to-use
Change in Gait Quality (Data capture from Heel2Toe sensor)
Technologically-reported outcome
Change in Lower Extremity Function (Neuroqol)
Patient-reported outcome on degree of difficulty with activities related lower extremity function
Change in Postural Instability and Gait Dysfunction (UPDRS)
Self-reported outcome of limitations
Change in health-related quality of life (EQ-5D-3L)
Patient-reported outcome (EQ-5D-3L)
Change in motivation (Starkstein Apathy Scale, Activity Effort Inventory)
Patient-reported outcome
Change in health states (Visual Analogue Health States)
Patient reported outcome of 8 health states measured on 0 to 10 scale
Cognitive performance (Symbol Digit Modality Test)
Performance-rated outcome

Full Information

First Posted
March 4, 2020
Last Updated
March 13, 2023
Sponsor
McGill University
search

1. Study Identification

Unique Protocol Identification Number
NCT04300348
Brief Title
Improving Walking With Heel-To-Toe Device
Official Title
Real-time Auditory Feedback for Improving Gait and Walking in People With Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
April 15, 2021 (Actual)
Primary Completion Date
October 30, 2022 (Actual)
Study Completion Date
October 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
McGill University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Introduction: The purpose of this study is to test the efficacy potential of using real-time positive auditory feedback to improve gait pattern in people with Parkinson's Disease (PD). The components of walking are commonly affected in patients with PD. Gait training for PD is usually based on verbal cues from the therapist that are only moderately effective. Based on good principals of gait and neuroplasticity, the Heel-To-Toe (Heel2Toe) sensor was developed to provide real-time auditory feedback during walking training. Methods: A two-group, randomized feasibility trial is planned with repeated measures of gait parameters and walking outcomes. Participants will be assessed at baseline, 3 and 6 months. Outcomes after the 5 training days will be obtained directly from the Hee2Toe device for both groups (with and without auditory feedback). The primary outcome is walking capacity measured by the Six-Minute Walk Test and the Standardized Walking Obstacle Course. Gait parameters will be captured by the Heel2Toe device Expected Contributions: Gait training using the Heel2Toe sensor will be potentially effective for improving walking pattern in people with PD.
Detailed Description
As this is a feasibility study, the main analysis will focus on within-group change over the intervention period of 3 months using indices of reliable change(36). This method assesses the number of people who changed in each of the groups based on the magnitude of change relative to pre-post variability and correlation. We will estimate the proportion of people with reliable change. Estimates from the pilot study will be used to plan the main trial if the pilot demonstrates feasibility. For the maintenance period, reliable change from baseline will also be estimated and used to identify the proportion of people who maintained reliable change or who gained/lost this status. The study is designed to detect a minimal important within-group change of moderate magnitude or greater (effect size ½ standard deviation) with adequate precision. A sample size of 20 in the intervention with completed follow-up will provide a 95% confidence interval with precision that excludes an effect size of 0.03.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson
Keywords
gait, walking capacity, neuroplasticity, motor learning, quality of life

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Standard two-group, sequential design, with 2:1 randomization (intervention:control) and only a within-group analysis.
Masking
Outcomes Assessor
Masking Description
An evaluator who does not know to which group the participant was assigned will conduct the evaluations. The outcomes are tests of performance.
Allocation
Randomized
Enrollment
27 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Heel2Toe Group
Arm Type
Active Comparator
Arm Description
The Heel2Toe group will have 5 therapy sessions to learn to trigger the sensor with a strong heel strike and how to use device for home practice for 3 months. During the home practice, participants will be instructed to walk with the device for a minimum of 10 minutes per day in feedback mode. They will be provided with a workbook outlining simple exercises targeting functions needed to walk well (Walk-BEST Workbook) in paper and as a mobile app.
Arm Title
No-feedback Control Group (Control group)
Arm Type
Other
Arm Description
The Control group will do the same 5 sessions of training and 3 months of practice but without the Heel2Toe device in feedback mode, just in data acquisition mode. They will be provided with a workbook outlining simple exercises targeting functions needed to walk well (Walk-BEST Workbook) in paper and as a mobile app.
Intervention Type
Device
Intervention Name(s)
Heel2Toe
Intervention Description
Heel to Toe (Heel2Toe) is a device that clips on the shoe and provides an instant auditory feedback (a beep) for each correct step characterized by putting the heel first and it provides data on gait parameters
Intervention Type
Other
Intervention Name(s)
No-feedback control group
Intervention Description
The control group will follow the same protocol as the Heel2Toe group but the device will not be in feedback mode just in data acquisition mode.
Primary Outcome Measure Information:
Title
Reliable Change in Six-Minute Walk Test
Description
Performance-rated outcome
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Title
Change in Standardized Walking Obstacle Course (SWOC)
Description
Performance-rated outcome of challenges experienced with starting, stopping, turning, making motor decisions. The metric is the time to complete a 12.2-m long, 0.92-m wide curved pathway, with obstacles commonly encountered in daily life.
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Secondary Outcome Measure Information:
Title
Safety (Falls)
Description
Self-reported number of falls during study period
Time Frame
Baseline to 3 months.
Title
Technology acceptability (System Usability Scale)
Description
Patient-reported outcome on satisfaction and intent-to-use
Time Frame
3 months (1 time point)
Title
Change in Gait Quality (Data capture from Heel2Toe sensor)
Description
Technologically-reported outcome
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)]
Title
Change in Lower Extremity Function (Neuroqol)
Description
Patient-reported outcome on degree of difficulty with activities related lower extremity function
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Title
Change in Postural Instability and Gait Dysfunction (UPDRS)
Description
Self-reported outcome of limitations
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Title
Change in health-related quality of life (EQ-5D-3L)
Description
Patient-reported outcome (EQ-5D-3L)
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Title
Change in motivation (Starkstein Apathy Scale, Activity Effort Inventory)
Description
Patient-reported outcome
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Title
Change in health states (Visual Analogue Health States)
Description
Patient reported outcome of 8 health states measured on 0 to 10 scale
Time Frame
Baseline, 3 months (Change from Baseline to 3 months; maintenance to 6 months)
Title
Cognitive performance (Symbol Digit Modality Test)
Description
Performance-rated outcome
Time Frame
Baseline, 3 months, 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Parkinson Disease and be independent in ambulation without use of walking aid Exclusion Criteria: exercising three or more time per week; Had any additional illness that restricted their function Showing difficulty reading, understanding or speaking either French or English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nancy Mayo, PhD
Organizational Affiliation
Research Institute - MUHC
Official's Role
Principal Investigator
Facility Information:
Facility Name
McGill University Health Center
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H4A 3S5
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30856128
Citation
Mate KKV, Abou-Sharkh A, Morais JA, Mayo NE. Putting the best foot forward: Relationships between indicators of step quality and cadence in three gait vulnerable populations. NeuroRehabilitation. 2019;44(2):295-301. doi: 10.3233/NRE-182595.
Results Reference
background
PubMed Identifier
31825320
Citation
Mate KK, Abou-Sharkh A, Morais JA, Mayo NE. Real-Time Auditory Feedback-Induced Adaptation to Walking Among Seniors Using the Heel2Toe Sensor: Proof-of-Concept Study. JMIR Rehabil Assist Technol. 2019 Dec 11;6(2):e13889. doi: 10.2196/13889.
Results Reference
background
PubMed Identifier
32650238
Citation
Carvalho LP, Mate KKV, Cinar E, Abou-Sharkh A, Lafontaine AL, Mayo NE. A new approach toward gait training in patients with Parkinson's Disease. Gait Posture. 2020 Sep;81:14-20. doi: 10.1016/j.gaitpost.2020.06.031. Epub 2020 Jun 29.
Results Reference
background
Links:
URL
http://physiobiometrics.com
Description
Website for the company that produces Heel2Toe(TM)

Learn more about this trial

Improving Walking With Heel-To-Toe Device

We'll reach out to this number within 24 hrs